Active	Status	Sponsor type	Region	Phase	Filter
8 Active 0 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Geng, Jiawei
NCT04683406: A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A	Completed	3	750	RoW	ZSP1273 600 mg, Placebo to Oseltamivir, Oseltamivir(oral), Placebo to ZSP1273	Guangdong Raynovent Biotech Co., Ltd	Influenza A	04/23	05/23
TQ-A3334-II-03, NCT06706310: Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection	Recruiting	2	116	RoW	Placebo, TQA3334 Tablet, Nucleoside (acid) analogs (NAs)	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Chronic Hepatitis B	12/25	06/26
NCT05755776: The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment	Recruiting	N/A	204	RoW	TMF, Heng Mu	The Second Affiliated Hospital of Chongqing Medical University, Jiangsu Hansoh Pharmaceutical Co., Ltd.	Chronic Hepatitis B	12/24	12/24